GLN-OLMESARTAN
GLENMARK PHARMACEUTICALS CANADA INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of GLN-OLMESARTAN in Canada?
Yes. GLN-OLMESARTAN 40MG has an active shortage reported to Health Canada (last updated October 29, 2026).
Why is GLN-OLMESARTAN not available?
The reason the manufacturer reported: Demand increase for the drug.
When will GLN-OLMESARTAN be available again?
The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACH-OLMESARTAN
ACCORD HEALTHCARE INC
Other Products
JAMP OLMESARTAN
JAMP PHARMA CORPORATION
SANDOZ OLMESARTAN
SANDOZ CANADA INCORPORATED
OLMETEC
ORGANON CANADA INC.
GLN-OLMESARTAN
GLENMARK PHARMACEUTICALS CANADA INC.
OLMESARTAN
PRO DOC LIMITEE
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02469820
Strength
40MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Demand increase for the drug.
Shortage of an inactive ingredient or component.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
30MG · DIN 02518910
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
10MG · DIN 02519860
600MG · DIN 02410990
800MG · DIN 02411008
20MG · DIN 02469812